EXEL240920C16000
- 10.40
- -0.10-0.95%
Exelixis Newsroom
Daily short sale tracking: Bank Bradesco SA(prefer share ADS)'s short volume increased by 4 million, with a short sale ratio of 17%
Bank Bradesco SA(prefer share ADS)(BBD.US) ranked top of the list had the largest change in short volume (4.11 million shares), and the short volume ratio of Exelixis(EXEL.US) reached 46.32%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
Does Exelixis (NASDAQ:EXEL) Deserve A Spot On Your Watchlist?
Unusual Options Activity: OVV, KKR and Others Attract Market Bets, OVV V/OI Ratio Reaches 190.3
EST Sep 10th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Optimistic Outlook for Exelixis With Growth Opportunities in Drug Development Pipeline
BofA Securities Maintains Exelixis(EXEL.US) With Buy Rating
BofA Securities analyst Jason Gerberry maintains $Exelixis(EXEL.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 43.7% and a total average return of 0.2% over the
Bank of America Securities Sticks to Its Buy Rating for Exelixis (EXEL)
Zacks.com Featured Highlights Genpact, MPLX, Exelixis, Paramount Global and H&R Block
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in September
Has Exelixis, Inc.'s (NASDAQ:EXEL) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Why Exelixis (EXEL) Might Be Well Poised for a Surge
Why Investors Shouldn't Be Surprised By Exelixis, Inc.'s (NASDAQ:EXEL) P/E
Kidney Cancer Drugs Global Strategic Business Report 2023-2030 With Focus on Key Players Including Bayer, Bristol-Myers Squibb, Eisai, Exelixis, Novartis, and Pfizer - ResearchAndMarkets.com
Insider Sale: Director Maria Freire Sells 8,250 Shares of Exelixis Inc (EXEL)
Exelixis (EXEL) Gains 14.9% in a Week on Strong Q2 Results
Investing in Exelixis (EXEL)? Don't Miss Assessing Its International Revenue Trends
Exelixis (EXEL) Receives a Buy From Wells Fargo
Exelixis Insider Sold Shares Worth $3,398,750, According to a Recent SEC Filing
Is Caligan Partners Bullish on Exelixis Inc (EXEL) Right Now?
Exelixis: Balancing Strong Financials With Operational Challenges in Berens's Hold Rating
Expert Outlook: Exelixis Through The Eyes Of 5 Analysts